Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Korea Builds Up Presence Further In Korea Through Merger With Wyeth Korea

This article was originally published in PharmAsia News

Executive Summary

SEOUL - With the Jan. 29 approval of South Korea's Fair Trade Commission, Pfizer swiftly integrated its operations with Wyeth Korea to become one entity Feb. 1
Advertisement

Related Content

Korea Labor Unions At Global Pharma Firms Band Together To Protect Jobs
Pfizer Will Seek Out More R&D Opportunities in Korea
Pfizer Will Seek Out More R&D Opportunities in Korea
Pfizer Lowers Targeted Revenues for 2012; Wall Street Remains Skeptical
Pfizer Signs MOU With Wuhan To Establish First R&D Center In Midwest China; Ranks Number One In China
Pfizer's Shanghai R&D Site To Serve As R&D Hub For Asia
Pfizer Korea Signs Development Pact With State KRIBB For Liver and Gastric Cancer Drugs
Kyowa Hakko’s Parkinson’s Drug Is Not Approvable – U.S. FDA
Advertisement
UsernamePublicRestriction

Register

SC074184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel